Stocksigma LogoStocksigma Logo

Mankind Pharma Schedules Board Meeting for Q2 FY27 Financial Results

Mankind Pharma Limited has scheduled its Board of Directors meeting for 26th Oct'26 to consider and approve the unaudited standalone and consolidated

Mankind Pharma Schedules Board Meeting for Q2 FY27 Financial Results

Mankind Pharma Ltd 路 Intimation 路 26 Oct 2026, 5:30 am

Mankind Pharma Schedules Board Meeting for Q2 FY27 Financial Results Mankind Pharma Limited has scheduled its Board of Directors meeting for 26th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for designated insiders until 28th Oct'26, in compliance with SEBI insider trading regulations.

Original exchange filing (PDF)

More announcements from Mankind Pharma Ltd

All Mankind Pharma Ltd announcements